Indogulf Cropsciences FY26: Growth Holds Up, But FY27 Has Weather and Cost Variables
Ask Iris
Indogulf Cropsciences closed FY26 with a strong top line and faster profit growth, even as the operating environment stayed choppy for agrochemicals. For FY26, revenue from operations rose to INR 7,046 million (INR 704.6 crore), up 19% year on year. EBITDA increased to INR 740 million (INR 74.0 crore), up 15%, and profit after tax came in at INR 400 million (INR 40.0 crore), up 27%.
Q4 FY26 followed a similar pattern on revenue, but margins were tighter. Revenue from operations was INR 1,508 million (INR 150.8 crore), up 19% year on year. EBITDA was INR 204 million (INR 20.4 crore), down 2%, while PAT rose 19% to INR 116 million (INR 11.6 crore). Management attributed the Q4 margin pressure to higher employee expenses, higher other operating expenses, and ongoing volatility in certain input prices.
The year’s results matter because they came alongside a clear push by the company to position itself beyond pure crop protection, toward an integrated crop-solutions platform spanning crop protection, plant nutrients, and biologicals. The story in FY26 was not only growth, but also mix improvement and the build-out of distribution and manufacturing readiness for the next phase.
FY26 performance in numbers and what changed
The company’s multi-year track record shows steady scaling, with FY26 operating revenue rising to INR 7,046 million from INR 5,904 million in FY25. Gross profit expanded to INR 2,181 million in FY26 and gross margin improved to 31.0% from 29.8% in FY25. EBITDA margin for the year was 10.4%.
In Q4, the operating leverage did not fully translate into higher EBITDA. The company reported Q4 FY26 EBITDA margin of 13.5% compared with 16.5% in Q4 FY25. On the call, management highlighted elevated employee costs and other operating costs during the quarter. Despite that, PAT margin in Q4 was stated as stable at 7.7%.
The key takeaway is that FY26 profitability improved mainly at the net profit level, while EBITDA margin stayed broadly stable for the year and dipped in Q4.
Portfolio mix: crop protection dominates, but growth themes are nutrients and biologicals
Indogulf’s revenue mix remains led by crop protection. The investor presentation disclosed FY26 revenue mix by verticals as crop protection 85%, biologicals 6%, plant nutrients 5%, and others 4%.
This mix matters for two reasons. First, it explains why the company’s near-term performance is still heavily linked to crop protection demand and seasonality. Second, it frames management’s stated strategy of moving “from products to solutions”. In the call, management emphasized that the integrated offering allows the company to engage farmers through multiple stages, including soil fertility, root development, flowering and fruiting, and protection.
The company also disclosed end-user mix for FY26: B2C at 50%, B2B at 38%, exports at 11%, and others at 0.1%. Management described B2C as supported by deeper farmer engagement and distribution reach, while B2B remained supported by institutional relationships.
Within product categories, the presentation disclosed an FY26 product mix of insecticides 59%, fungicides 29%, herbicides 11%, and fertilizers 1%. Management also shared a measurable data point on the call: specialty products launched over the last three years contributed around 16% of FY26 revenue. For FY27, management mentioned plans to launch three new products: one in nutrients, one herbicide combination (Fomesafen plus Quizalofop), and one fungicide planned around August following a patent expiry.
Distribution, exports, and AGPL: scaling the channel engine
The company’s distribution narrative rests on both reach and engagement. The presentation highlighted 7,000-plus distributors, 30 stock depots, and 100,000-plus farmers engaged. Management repeatedly linked growth to field execution through IDOs (development officers), farmer meetings, and demonstrations.
A second layer is AGPL (AbhiPrakash Globus Private Limited), positioned as a secondary penetration and multi-brand expansion strategy. Management described AGPL as a platform to deepen access in territories where Indogulf’s traditional channels may have limited reach. On the call, the company stated that around 1,300 to 1,400 channel partners were added last year and that expansion into Chhattisgarh and Odisha is in progress.
Exports are still a smaller part of the mix at 11% of FY26 revenue, but management framed them as a long-term lever. The presentation referenced 34-plus countries and 140-plus active overseas partners. FY26 developments included a fertilizer shipment to Venezuela, engagements in Taiwan (Spiromesifen technical and Mancozeb expansion), and successful field trials in Sri Lanka for Indo Apache. Management also pointed to reduced Chinese export incentives as a potential opportunity for compliant Indian manufacturers.
At the same time, management flagged the other side of the export story: geopolitical tension in West Asia can increase volatility in crude prices and logistics costs, which can flow into agrochemical raw material pricing.
Manufacturing and capex: utilization improving, expansion timelines depend on approvals
Indogulf operates four manufacturing facilities: Nathupur I (formulations), Nathupur II (technical), Barwasni (advanced formulations), and Samba (Jammu and Kashmir). The investor presentation showed capacity utilization rising to 52% in FY26, compared with 46% in FY25 and 44% in FY23.
The central operational project discussed was the expansion at the Barwasni facility, including a dry flowable manufacturing plant. On the call, management stated that the construction phase is almost over, but multiple regulatory permissions and licenses are pending. It also cited construction stoppages in NCR due to GRAP restrictions as a reason for delays.
Management indicated commissioning is expected by end of Q3 FY27. It also disclosed capex spent to date of around INR 76 crore, with a further INR 8 to 10 crore planned. In a separate response, management stated that the expanded capacity has the potential to support a topline as high as INR 1,600 to 1,800 crore at higher utilization, while avoiding a hard commitment on the timeline.
FY27 watchpoints: El Nino risk and input volatility, with near-term cover for Q1
Management commentary for FY27 was cautious but not defensive. It highlighted El Nino as a monitorable factor that could influence sowing patterns and demand. As a partial offset, management pointed to cotton as a crop that could remain resilient in certain regions and tends to require high insecticide usage.
On raw materials, the company stated that Q1 FY27 requirements are largely secured, while prolonged volatility could affect Q2 FY27 procurement cycles and costs. Management also referenced backward integration and said captive consumption in Q4 was around 32%, which it views as a buffer for availability and certain cost advantages.
Takeaways
Indogulf’s FY26 outcome was clear: 19% revenue growth with 27% PAT growth, backed by improved gross margins and steady scaling of distribution and manufacturing utilization. The integrated solutions narrative is supported by disclosed mix data and on-ground engagement metrics, while AGPL adds a second channel engine aimed at underserved markets.
The near-term debate for FY27 is less about demand ambition and more about execution and external variables. Weather patterns and raw material volatility can swing quarterly profitability, and the Barwasni expansion schedule depends on approvals. The company’s own framing suggests Q1 is covered on inputs, while Q2 could be more sensitive.
If Indogulf sustains mix improvement and executes the Barwasni scale-up while navigating weather and input costs, FY26 looks like a base year for the next phase rather than a one-off spike.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
